Anebulo Pharmaceuticals

ANEB

OTCHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-8M

EBITDA$-7.43M

EBIT$-7.43M

Pre-tax Income$-8.48M

Net Income$-7.67M

Net Cash$116.28M

Cash Equivalent$6.16M

Total Debt$0

Net Debt$-116.28M

Book Value$6.41M

Net Cash Per Share2.83

Book Value Per Share0.25

Return on Equity (ROE)-215.12%

Return on Assets (ROA)-201.36%

Return on Invested Capital (ROI)-215.12%

Net Profit Marginundefined

Current Ratio13.46

Quick Ratio11.87

Long-Term Debt / Equitynull